432 filings
Page 7 of 22
S-8
pjk0udgti
26 Jun 20
Registration of securities for employees
5:01pm
8-K
m5y2zu6
26 Jun 20
Soleno Therapeutics Announces Pricing of $50 Million Public Offering of Common Stock
4:31pm
424B5
lp8hv43dh2hu6
25 Jun 20
Prospectus supplement for primary offering
4:01pm
424B5
8s63o
23 Jun 20
Prospectus supplement for primary offering
4:06pm
8-K
cu1 0sjlojqcf2f
8 Jun 20
Regulation FD Disclosure
5:04pm
8-K
z1zmjf4m99fuog0xjmh0
19 May 20
Departure of Directors or Certain Officers
5:20pm
8-K
z2u72v u0
12 May 20
Soleno Therapeutics Provides Corporate Update and Reports First Quarter 2020 Financial Results
4:05pm
8-K
zcnwsy
28 Apr 20
Entry into a Material Definitive Agreement
4:03pm
8-K
b7nyj7rn
20 Apr 20
Departure of Directors or Certain Officers
4:01pm
8-K
gv3m8jdnytdkd2fo
4 Mar 20
Soleno Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2019 Financial Results
4:17pm
8-K
z3m5vutwtmod7shx399k
24 Jan 20
Departure of Directors or Certain Officers
4:11pm
S-8
tn5svlgs
21 Jan 20
Registration of securities for employees
5:30pm
8-K
zdlgs
10 Jan 20
Regulation FD Disclosure
5:16pm
8-K
6bmew0cqsyqub5zuspmo
6 Jan 20
Soleno Therapeutics Completes Target Enrollment in Ongoing DESTINY PWS Phase III Trial of DCCR in Prader Willi Syndrome
5:01pm
8-K
0iqy62euszbxge 7nf
15 Nov 19
Departure of Directors or Certain Officers
4:37pm